NL-OMON24514RecruitingNot Applicable
iposoluble vitamins in patients receiving long-term octreotide treatment.
prof. dr. EGE de VriesUniversitair Medisch Centrum Groningen9700 RB Groningenthe Netherlands0 sites80 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 80
Study Overview
Brief Summary
/A
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Patients are eligible when they have used octreotide for at least 18 months. Patients must be 18 years or older and must be willing to give written informed consent.
Exclusion Criteria
- •No informed consent, age less then 18 years.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
iposoluble vitamins in patients receiving long-term octreotide treatmentliposoluble vitamin deficiencyshortage of liposoluble vitamins10047635NL-OMON32903niversitair Medisch Centrum Groningen80
Completed
Not Applicable
Vitamine suppletion by morbide obase patientNL-OMON39275Alysis Zorggroep400
Completed
Phase 4
Vitamin Deficiencies and Supplementation in Morbidly obeseNL-OMON38253Rijnstate Ziekenhuis50
Active, not recruiting
Not Applicable
Vitamin deficiencies and supplement in overweight patientsVitamin B12 deficienciesEUCTR2013-004835-60-NLRijnstate Hospital
Completed
Not Applicable
Vitamin Replacement in AbetalipoproteinemiaAbetalipoproteinemiaNCT00004574National Heart, Lung, and Blood Institute (NHLBI)1